In this Pipeline Accelerator round, Phenomics Australia is partnering with TIA, ANSTO’s National Deuteration Facility and Bioplatforms Australia to expand the list of translation expertise necessary for the discovery and translation of medical research. This scheme aims to support therapeutic development projects by providing up to $50,000 with at least 50% matching funding (co-investment) by the applicant.
Applications close on Friday 31st of October 2025, 5pm (AEST).






